Jueyin granules

also known as JYG · JYKL

Developed for: psoriasis
Investigated by: Shanghai Yueyang Integrated Medicine Hospital · Beijing Hospital of Traditional Chinese Medicine · Chinese Medicine Hospital Affiliated to Southwest Medical University · Gansu University of Chinese Medicine · Guangxi Zhuang Autonomous Region Dermatology Hospital · Jiangsu Province Hospital of Traditional Chinese Medicine
+5 more
· Shanghai Dermatology Hospital · Shanghai Skin Disease and Venereal Disease Hospital · The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine · The Second People's Hospital Affiliated to Fujian University of TCM · Wuhan No.1 Hospital

2020202120222023202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 22 trials
Phase 2	NCT03961230	Jun 2019 → Dec 2021	psoriasis	Shanghai Yueyang Integrated Medicine Hospital	Unknown	No outcome recorded
Phase 2	NCT03941431	Jun 2019 → Dec 2021	psoriasis	Shanghai Yueyang Integrated Medicine Hospital	Unknown	No outcome recorded
Phase not applicable1 trial
—	NCT05042635	Oct 2021 → Sep 2024	psoriasis	Shanghai Yueyang Integrated Medicine Hospital	Unknown	No outcome recorded

Every value below carries the sentence it was read from. 5 sources stand behind the page.

Field	Value	Cited text
Known as	Jueyin Granules	ClinicalTrials.gov intervention name — accepted as the source's own label NCT05042635 ↗ 2 NCT03941431 ↗ NCT03961230 ↗
Known as	JYG	“Patients with mild-to-moderate psoriasis (n=107) were randomized to receive oral Jueyin granules (JYG) or moving cupping treatment for 4 weeks” PMID 40135074 ↗ Mar 2025
Known as	JYKL	“using Jueyin granules (JYKL)” PMID 32351609 ↗ Apr 2020
Modality	Traditional medicine (herbal / TCM)	“The treatments involved in this study include cupping, phototherapy, and Chinese medicine.” NCT03941431 ↗
Route	Oral	“Jueyin granules p.o. once a day for 8 weeks.” NCT03941431 ↗